3 results match your criteria: "Harvard Medical School and the Howard Hughes Medical Institute[Affiliation]"
Nat Immunol
April 2002
Division of Hematology and Oncology, Dana-Farber Cancer Institute and Children's Hospital, Department of Pediatrics, Harvard Medical School and the Howard Hughes Medical Institute, Boston, MA 02115, USA.
Hematopoietic stem cells (HSCs) provide for blood formation throughout the life of the individual. Studies of HSCs form a conceptual framework for the analysis of stem cells of other organ systems. We review here the origin of HSCs during embryological development, the relationship between hematopoiesis and vascular development and the potential plasticity of HSCs and other tissue stem cells.
View Article and Find Full Text PDFJ Biol Chem
March 2002
Department of Pathology, Harvard Medical School and the Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA.
The activity of cyclin-dependent kinase-5 (Cdk5) is tightly regulated by binding of its neuronal activators p35 and p39. Upon neurotoxic insults, p35 is cleaved to p25 by the Ca(2+)-dependent protease calpain. p25 is accumulated in ischemic brains and in brains of patients with Alzheimer's disease.
View Article and Find Full Text PDFCancer Res
April 1999
Division of Hematology, Children's Hospital and the Dana Farber Cancer Center, Harvard Medical School and the Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA.
Hematopoietic development is regulated in large part by transcription factors that control cell fate decisions and cellular differentiation. Several genes first discovered in the context of chromosomal translocations in leukemia also serve important functions in blood cell development. Gene-targeting experiments related to two of these factors, SCL/tal-1 and translocation-ets-leukemia (TEL), are reviewed here.
View Article and Find Full Text PDF